货号： 31985070

规格

内容及储存

Storage conditions: 2-8°C. Protect from light.
Shipping conditions: Ambient.
Shelf life: 18 months from date of manufacture.

描述

Opti-MEM® Reduced-Serum Medium is an improved Minimal Essential Medium (MEM) that allows for a reduction of Fetal Bovine Serum supplementation by at least 50% with no change to growth rate or morphology. Opti-MEM® is also recommended for use with cationic lipid transfection reagents, such as Lipofectamine™ reagent. Opti-MEM® can be used with a variety of suspension and adherent mammalian cells, including Sp2, AE-1, CHO, BHK-21, HEK, and primary fibroblasts. Life Technologies offers a variety of Gibco® Opti-MEM® modifications  for a range of cell culture applications.

This Opti-MEM® is modified as follows:

The complete formulation is confidential. For more information, please contact Technical Services .

Gibco® Opti-MEM® is a unique media that contains insulin, transferrin, hypoxanthine, thymidine, and trace elements. These additional components allow for a reduction in serum supplementation by at least 50%.

Product Intended Use
For in vitro diagnostic use. CAUTION: Not for human or animal therapeutic use. Uses other than the intended use may be a violation of local law.

cGMP Manufacturing and Quality System
Gibco® Opti-MEM® is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 and ISO 9001 standards. For supply chain continuity, Life Technologies offers an identical Gibco® Opti-MEM® product made in our Scotland facility (31985-047). This facility is registered with the FDA as a medical device manufacturer and is certified to the ISO 13485 standard.

Gibco® Opti-MEM® uses a sodium bicarbonate buffer system (2.4 g / L) and therefore requires a 5-10% CO₂ environment to maintain physiological pH.

在中国境内, 本产品仅限于非临床科研用途, 产品信息以中文为准。 (In China territory, the product is for Research Use only in non-clinical unit, product information in Chinese shall prevail.)